Search Clinical Trials
597,593 trials
ID
Status
Phase
Title
Sponsor
NCT07755020
Nitride-Based Raman Biochip for Lung Cancer Diagnosis and MonitoringFar Eastern Memorial HospitalRecruiting
NCT07755020Recruiting
—
Nitride-Based Raman Biochip for Lung Cancer Diagnosis and MonitoringFar Eastern Memorial Hosp...
NCT07754812
Oral Paclitaxel Solution With Immunotherapy and Concurrent SBRT as Neoadjuvant Treatment for Older Adults With NSCLCShanghai Pulmonary Hospital, Shanghai, ChinaRecruitingPhase 4
NCT07754812Recruiting
Phase 4
Oral Paclitaxel Solution With Immunotherapy and Concurrent SBRT as Neoadjuvant T...Shanghai Pulmonary Hospit...
NCT07755332
Association Between Central Sensitization and the Root Mean Square of Successive DifferencesIstanbul Demiroglu Bilim UniversityCompleted
NCT07755332Completed
—
Association Between Central Sensitization and the Root Mean Square of Successive...Istanbul Demiroglu Bilim...
NCT07754747
Effects of Vestibular-Oriented Balance Training Versus Motor Dual Task Training on Balance, Postural Control, and Fall Risk in Chronic Stroke SurvivorsIbadat International University, IslamabadRecruitingNot Applicable
NCT07754747Recruiting
Not Applicable
Effects of Vestibular-Oriented Balance Training Versus Motor Dual Task Training...Ibadat International Univ...
NCT07754097
Self-Management Data and Disease Progression in Chronic Kidney DiseaseChungnam National University HospitalRecruiting
NCT07754097Recruiting
—
Self-Management Data and Disease Progression in Chronic Kidney DiseaseChungnam National Univers...
NCT07755046
Repetitive Transcranial Magnetic Stimulation for Alcohol Use DisorderTing-Gang ChangCompletedNot Applicable
NCT07755046Completed
Not Applicable
Repetitive Transcranial Magnetic Stimulation for Alcohol Use DisorderTing-Gang Chang
NCT07753928
PENTAGON: MS-Related Disability Worsening and Thalamic Volume LossJung Diagnostics GmbHEnrolling By Invitation
NCT07753928Enrolling By Invitation
—
PENTAGON: MS-Related Disability Worsening and Thalamic Volume LossJung Diagnostics GmbH
NCT07756008
Bladder-Sparing Treatment With Disitamab Vedotin and Toripalimab With or Without Pelvic Lymph Node Dissection in Bladder CancerSun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot Yet RecruitingPhase 2
NCT07756008Not Yet Recruiting
Phase 2
Bladder-Sparing Treatment With Disitamab Vedotin and Toripalimab With or Without...Sun Yat-Sen Memorial Hosp...
NCT07754357
Ultrasound-Guided T2 Erector Spinae Plane Block Versus Intercostobrachial Block in AV Fistula Surgery.Aswan University HospitalEnrolling By InvitationNot Applicable
NCT07754357Enrolling By Invitation
Not Applicable
Ultrasound-Guided T2 Erector Spinae Plane Block Versus Intercostobrachial Block...Aswan University Hospital
NCT07754721
Comprehensive Management Strategies for Gastroesophageal Reflux Disease: A Study of Multidimensional Interventions and Health ImpactsHualien Tzu Chi General HospitalRecruitingNot Applicable
NCT07754721Recruiting
Not Applicable
Comprehensive Management Strategies for Gastroesophageal Reflux Disease: A Study...Hualien Tzu Chi General H...
NCT07754513
Circulating Tumor Extracellular Vesicles for Non-Invasive Monitoring of Metastatic Colorectal CancerFondazione Policlinico Universitario Agostino Gemelli IRCCSNot Yet Recruiting
NCT07754513Not Yet Recruiting
—
Circulating Tumor Extracellular Vesicles for Non-Invasive Monitoring of Metastat...Fondazione Policlinico Un...
NCT07754175
A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and Efficacy of FURESTEM-OA-Kit Inj. in Knee Osteoarthritis Patients Who Received Placebo in the K0701 Phase 2a TrialKang Stem Biotech Co., Ltd.Recruiting
NCT07754175Recruiting
—
A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and...Kang Stem Biotech Co., Lt...
NCT07756424
Implementation of a Disparities in Labor Outcomes DashboardEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Not Yet RecruitingNot Applicable
NCT07756424Not Yet Recruiting
Not Applicable
Implementation of a Disparities in Labor Outcomes DashboardEunice Kennedy Shriver Na...
NCT07754552
DEVELOPMENT AND EVALUATION OF THE EFFECTIVENESS OF THE SMART-HAND PROTOCOL FOR HAND REHABILITATION IN PATIENTS WITH RHEUMATOID ARTHRITISIstanbul University - CerrahpasaNot Yet RecruitingNot Applicable
NCT07754552Not Yet Recruiting
Not Applicable
DEVELOPMENT AND EVALUATION OF THE EFFECTIVENESS OF THE SMART-HAND PROTOCOL FOR H...Istanbul University - Cer...
NCT07754929
E-Mergir: A Digital Psychosexual Intervention for the Promotion of Mental and Sexual Health of Prostate Cancer SurvivorsUniversidade do PortoRecruitingNot Applicable
NCT07754929Recruiting
Not Applicable
E-Mergir: A Digital Psychosexual Intervention for the Promotion of Mental and Se...Universidade do Porto
NCT07754396
Effect of Tranexamic Acid on Bleeding After Bariatric SurgeryG.Gennimatas General HospitalCompleted
NCT07754396Completed
—
Effect of Tranexamic Acid on Bleeding After Bariatric SurgeryG.Gennimatas General Hosp...
NCT07755124
Dietary Arginine Deprivation Combined With Chemoradiotherapy for Neoadjuvant Treatment of Rectal Cancer: A Randomized Controlled TrialWest China HospitalNot Yet RecruitingPhase 1
NCT07755124Not Yet Recruiting
Phase 1
Dietary Arginine Deprivation Combined With Chemoradiotherapy for Neoadjuvant Tre...West China Hospital
NCT07756164
The Effects of a Multicomponent Sleep & Recovery Supplement on Muscle Fatigue and SleepUniversity of ExeterNot Yet RecruitingNot Applicable
NCT07756164Not Yet Recruiting
Not Applicable
The Effects of a Multicomponent Sleep & Recovery Supplement on Muscle Fatigue an...University of Exeter
NCT07755826
Repotrectinib Post-Marketing Surveillance in Pediatric Patients With NTRK Fusion-Positive Tumors in JapanBristol-Myers SquibbRecruiting
NCT07755826Recruiting
—
Repotrectinib Post-Marketing Surveillance in Pediatric Patients With NTRK Fusion...Bristol-Myers Squibb
Result Breakdown
Recruiting9 (45%)
Not yet recruiting6 (30%)
Completed3 (15%)
Enrolling by invitation2 (10%)
not_applicable9 (45%)
Not Specified8 (40%)
Phase 41 (5%)
Phase 21 (5%)
Phase 11 (5%)